Vivos (RDGL) Change in Cash (2010 - 2025)
Vivos (RDGL) reported Change in Cash of -$643584.0 for Q4 2025, down 164.72% on a YoY basis from $994388.0 in Q4 2024, and down 40.37% sequentially from -$458481.0 in Q3 2025.
Vivos (RDGL) Change in Cash (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of Change in Cash data on file, last reported at -$643584.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Cash fell 164.72% year-over-year to -$643584.0; the trailing twelve-month figure through Dec 2025 stood at -$654023.0 (down 205.44% YoY), and the FY2025 full-year result was -$654023.0, down 205.44% from the prior year.
- Change in Cash retreated to -$643584.0 in Q4 2025, from -$458481.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $1.6 million in Q1 2021 to a low of -$643584.0 in Q4 2025.
- A 5-year average of $32741.0 and a median of -$216690.5 in 2023 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash soared 10558.09% in 2021 and sank 270.96% in 2025, its largest moves.
- Tracing RDGL's Change in Cash over 5 years: stood at -$380468.0 in 2021, then rose by 25.97% to -$281667.0 in 2022, then surged by 119.68% to $55443.0 in 2023, then jumped by 1693.53% to $994388.0 in 2024, then slumped by 164.72% to -$643584.0 in 2025.
- Business Quant data shows RDGL's Change in Cash at -$643584.0 in Q4 2025, -$458481.0 in Q3 2025, and -$604510.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn | 199.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -2.23 Bn |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | -282.15 Mn |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | -643,584.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -643,584.00 |
| Sep 30, 2025 | -458,481.00 |
| Jun 30, 2025 | -604,510.00 |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 994,388.00 |
| Sep 30, 2024 | -506,257.00 |
| Jun 30, 2024 | 353,588.00 |
| Mar 31, 2024 | -221,458.00 |
| Dec 31, 2023 | 55,443.00 |
| Sep 30, 2023 | -211,923.00 |
| Jun 30, 2023 | 336,327.00 |
| Mar 31, 2023 | -293,625.00 |
| Dec 31, 2022 | -281,667.00 |
| Sep 30, 2022 | 937,026.00 |
| Jun 30, 2022 | -171,119.00 |
| Mar 31, 2022 | -384,298.00 |
| Dec 31, 2021 | -380,468.00 |
| Sep 30, 2021 | -178,078.00 |
| Jun 30, 2021 | -347,176.00 |
| Mar 31, 2021 | 1.61 Mn |